{"symbol":"ABT","fiscalQuarter":"Q1-2021","reportDate":"2021-04-20","reportTime":"BMO","status":"reported","company":{"name":"Abbott Laboratories","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABT/earnings/Q1-2021","postBrief":{"headline":"Abbott Labs Misses on EPS, Stock Down 3.64%","keyNumbers":[{"metric":"EPS","actual":"$1.32","expected":"N/A","surprise":"-0.98%"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management noted ongoing challenges but expressed confidence in long-term growth.","They highlighted the importance of innovation in driving future performance."],"summary":"Overall, management acknowledged the current difficulties while emphasizing their commitment to strategic initiatives. They remain focused on long-term goals despite short-term setbacks."},"guidanceChanges":{"summary":"No guidance updates were provided during the earnings call.","changes":[]},"whatItMeans":"Abbott Labs reported a slight miss on EPS, which contributed to a 3.64% decline in stock price following the earnings announcement. The lack of revenue data and guidance updates may have added to investor uncertainty. Management's cautious tone suggests they are navigating challenges but remain focused on future growth opportunities.","metaDescription":"Abbott Labs (ABT) Q1 2021 earnings: EPS missed expectations. Stock down 3.64%. Full breakdown."}}